Amgen Inc. BDR (AMGN34) Habari na Bei kuhusu Hisa

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia

Kuhusu Amgen Inc. BDR

Afisa Mkuu Mtendaji (CEO)Robert A. Bradway

Wafanyakazielfu 31.5

Lilianzishwa1980

Makao makuuThousand Oaks, California, Marekani

Sekta-

Tovutiamgen.com

Thamani zote katika USD	Sep 2025	Des 2025	Mac 2026	Jun 2026
Mapato	9.56B	9.87B	8.62B	10.05B
Gharama ya bidhaa zilizouzwa	2.74B	2.68B	2.50B	2.75B
Gharama ya mapato	2.74B	2.68B	2.50B	2.75B
Gharama za utafiti na maendeleo	1.90B	2.14B	1.72B	1.87B
Jumla ya gharama za utafiti na maendeleo	-	-	-	-
Gharama za uuzaji, za jumla na za usimamizi	1.72B	1.95B	1.60B	1.74B
Gharama ya uendeshaji	3.55B	4.18B	3.21B	3.73B
Jumla ya gharama za uendeshaji	6.29B	6.85B	5.70B	6.48B
Mapato ya uendeshaji	3.26B	3.01B	2.91B	3.57B
Mapato mengine yasiyo ya uendeshaji	181.00M	143.00M	192.00M	145.00M
EBT ikijumuisha vipengee visivyo vya kawaida	3.92B	1.51B	2.08B	2.77B
EBT bila kujumuisha vipengee visivyo vya kawaida	2.72B	2.51B	2.37B	3.06B
Gharama ya kodi ya mapato	705.00M	181.00M	265.00M	393.00M
Kiwango cha kodi kinachotumika	17.98%	11.96%	12.72%	14.20%
Gharama nyingine za uendeshaji	-71.00M	82.00M	-113.00M	116.00M
Mapato halisi	3.22B	1.33B	1.82B	2.38B
Kiwango cha faida halisi	33.65%	13.51%	21.11%	23.62%
Mapato kwa kila hisa	5.64	5.29	5.15	6.29
Mapato ya riba na uwekezaji	-	408.00M	-	-
Gharama ya riba	-685.00M	-1.06B	-657.00M	-673.00M
Jumla ya gharama halisi za riba	-685.00M	-653.00M	-657.00M	-673.00M
Gharama za kushuka kwa thamani na za kulipa deni	-	-	-	-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni	4.57B	4.02B	4.03B	4.69B
Faida au hasara kutokana na uuzaji wa vipengee	-	-	-	-

Fedha

Uliza chochote